PMID: 9645443Jun 30, 1998Paper

Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer

Virchows Archiv : an International Journal of Pathology
R SilvestriniG Ravasi

Abstract

The bcl-2 proto-oncogene functions as a cell death suppressor, and its expression prolongs cell survival by blocking apoptosis. Data available on the clinical relevance of bcl-2 protein expression in patients with non-small-cell lung cancer (NSCLC) are controversial. We analysed the role of bcl-2 protein expression on 6-year relapse-free survival in 229 patients with stage I-IIIa NSCLC (101 squamous cell carcinomas and 128 adenocarcinomas) subjected to surgery, with curative intent. Immunohistochemical analysis was performed on archival material by using a monoclonal antibody anti-bcl-2 (clone 124). Bcl-2 protein expression, which was detected in 22% of the cases, was significantly related to stage, histology and grading, and was an indicator of clinical outcome. The probability of relapse-free survival at 6 years was longer for patients with bcl-2-positive tumours (74%) than for those with bcl-2-negative tumours (57%) (P=0.02). This finding was mainly evident for the subgroups of patients with stage IIIa tumours (P=0.05), squamous cell carcinoma (P=0.03) or moderately/poorly differentiated tumours (P=0.02). However, multivariate analysis by Weibull's regression model indicated that bcl-2 protein expression was not an independe...Continue Reading

Citations

Aug 9, 2001·International Journal of Cancer. Journal International Du Cancer·S RorkeS C Tang
Sep 29, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·K Junker
Oct 26, 2002·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·V RigauJ M Bréchot
Sep 27, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M TomitaT Onitsuka
Mar 9, 2000·Pancreas·T MeggiatoG Del Favero
Jul 19, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Lars Henning SchmidtRainer Wiewrodt
May 11, 2005·Biochemical and Biophysical Research Communications·Sudip SenNeeta Singh
Apr 25, 2015·The EPMA Journal·Godfrey GrechDominic M Desiderio
Mar 15, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eelco FokkemaHarry J M Groen
May 28, 2004·Applied Immunohistochemistry & Molecular Morphology : AIMM·Leos KrenJeffrey S Ross
Feb 24, 2001·Annals of the New York Academy of Sciences·B JosephB Zhivotovsky
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roy S Herbst, Stanley R Frankel
Jun 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil SinghalSteven M Albelda

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.